Dana M. Hayden
Research Subjects
Research Interests
Dana M. Hayden has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Maria Mora Pinzon
Wisconsin Alzheimer's Institute, University of Wisconsin ‐ Madison, Madison, WI, USA
2 shared publications - Ali Keshavarzian
Rush Center for Integrated Microbiome and Chronobiology Research, Rush University Medical Center, Chicago, USA
1 shared publication Amanda B. B.A. Francescatti
Department of General Surgery, Section of Colon and Rectal Surgery, Rush University Medical Center, Chicago, Illinois
1 shared publicationChair
Division of Colon and Rectal Surgery, University of Wisconsin
1 shared publicationChristopher Forsyth
1 shared publicationDaniel Neubauer
1 shared publication
Latest Publications
- 11 October 2022
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 65 (12) , 1434-1435
Management of Acute Colonic Pseudo-Obstruction: What to Do When the Colon Is Doing Nothing
An abstract is unavailable. This article is available as a PDF only.
- 11 October 2022
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 65 (12) , 1434-1435
Management of Acute Colonic Pseudo-Obstruction: What to Do When the Colon Is Doing Nothing
An abstract is unavailable. This article is available as a PDF only.
- 24 February 2021
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 34 (02) , 121-126
Special Situations in the Management of Diverticular Disease
Diverticular disease affects a large percentage of the US population, affecting over 30% among those older than 45 years old. It is responsible for ∼300,000 hospitalizations per year in the United States and can lead to serious complications such as hemorrhage, obstruction, abscess, fistulae, or bowel perforation.[2] It is an extremely common reason for emergency room and outpatient visits and evaluations by general and colorectal surgeons. In the US, patients usually present with sigmoid diverticulitis in the setting of a normal immune system so surgeons will follow well-established practice guidelines for treatment. However, there may be special circumstances in which the management of diverticulitis is not as straightforward. In this article, we will address patients who present with multifocal disease, giant colonic diverticulum, right-sided diverticulitis, and diverticulitis in the setting of immunosuppression and hopefully provide guidance for treatment in these special circumstances. Publication Date: 24 February 2021 (online) © 2021. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 24 February 2021
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 34 (02) , 121-126
Special Situations in the Management of Diverticular Disease
Diverticular disease affects a large percentage of the US population, affecting over 30% among those older than 45 years old. It is responsible for ∼300,000 hospitalizations per year in the United States and can lead to serious complications such as hemorrhage, obstruction, abscess, fistulae, or bowel perforation.[2] It is an extremely common reason for emergency room and outpatient visits and evaluations by general and colorectal surgeons. In the US, patients usually present with sigmoid diverticulitis in the setting of a normal immune system so surgeons will follow well-established practice guidelines for treatment. However, there may be special circumstances in which the management of diverticulitis is not as straightforward. In this article, we will address patients who present with multifocal disease, giant colonic diverticulum, right-sided diverticulitis, and diverticulitis in the setting of immunosuppression and hopefully provide guidance for treatment in these special circumstances. Publication Date: 24 February 2021 (online) © 2021. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 October 2014
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 219 (4) , e75
Postoperative computed tomography (CT) scan after laparoscopic colorectal surgery: what does that fluid mean?
- 1 October 2014
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 219 (4) , e75
Postoperative computed tomography (CT) scan after laparoscopic colorectal surgery: what does that fluid mean?
- 7 December 2013
- Published by Springer Nature
- p. 173-183
Rectal Prolapse: Current Evaluation, Management, and Treatment of a Historically Recurring Disorder
- 7 December 2013
- Published by Springer Nature
- p. 173-183
Rectal Prolapse: Current Evaluation, Management, and Treatment of a Historically Recurring Disorder
- 1 December 2012
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 55 (12) , 1206-1212
Tumor Scatter After Neoadjuvant Therapy for Rectal Cancer
BACKGROUND: After the impressive response of rectal cancers to neoadjuvant therapy, it seems reasonable to ask: can we can excise the small ulcer locally or avoid a radical resection if there is no gross residual tumor? Does gross response reflect what happens to tumor cells microscopically after radiation? OBJECTIVE: The aim of this study was to identify microscopic tumor cell response to radiation. DESIGN: This study is a retrospective review of a prospectively collected database. SETTING: This investigation was conducted at a single tertiary medical center. PATIENTS: Patients were selected who had elective radical resection for rectal cancer after preoperative chemotherapy and radiation performed by 2 colorectal surgeons between 2006 and 2011. MAIN OUTCOME MEASURES: The primary outcome measured was tumor presence after radiation therapy RESULTS: Of the 75 patients, 20 patients were complete responders and 55 had residual cancer. Of these patients, 28 had no tumor cells seen outside the gross ulcer, and 27 (49.1%) had tumor outside the visible ulcer or microscopic tumor present with no overlying ulcer. Of these tumors, 81.5% were skewed away from the ulcer center. The mean distance of distal scatter was 1.0 cm from the visible ulcer edge to a maximum of 3 cm; 3 patients had tumor cells more than 2 cm distal to the visible ulcer edge. Tumor scatter outside the ulcer was not associated with poor prognostic factors, such as nodal and distant disease, perineural invasion, or mucin; however, it was associated with lymphovascular invasion (χ2 = 4.12, p = 0.038) LIMITATIONS: There was limited access to clinical information gathered outside our institution. CONCLUSIONS: Our study suggests that 1) after radiation, the gross ulcer cannot be used to determine the sole area of potential residual tumor, 2) cancer cells may be found up to 3 cm distally from the gross ulcer, so the traditional 2-cm margin may not be adequate, and 3) local excision of the ulcer or no excision after apparent complete response appears to be insufficient treatment for rectal cancer.
- 1 December 2012
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 55 (12) , 1206-1212
Tumor Scatter After Neoadjuvant Therapy for Rectal Cancer
BACKGROUND: After the impressive response of rectal cancers to neoadjuvant therapy, it seems reasonable to ask: can we can excise the small ulcer locally or avoid a radical resection if there is no gross residual tumor? Does gross response reflect what happens to tumor cells microscopically after radiation? OBJECTIVE: The aim of this study was to identify microscopic tumor cell response to radiation. DESIGN: This study is a retrospective review of a prospectively collected database. SETTING: This investigation was conducted at a single tertiary medical center. PATIENTS: Patients were selected who had elective radical resection for rectal cancer after preoperative chemotherapy and radiation performed by 2 colorectal surgeons between 2006 and 2011. MAIN OUTCOME MEASURES: The primary outcome measured was tumor presence after radiation therapy RESULTS: Of the 75 patients, 20 patients were complete responders and 55 had residual cancer. Of these patients, 28 had no tumor cells seen outside the gross ulcer, and 27 (49.1%) had tumor outside the visible ulcer or microscopic tumor present with no overlying ulcer. Of these tumors, 81.5% were skewed away from the ulcer center. The mean distance of distal scatter was 1.0 cm from the visible ulcer edge to a maximum of 3 cm; 3 patients had tumor cells more than 2 cm distal to the visible ulcer edge. Tumor scatter outside the ulcer was not associated with poor prognostic factors, such as nodal and distant disease, perineural invasion, or mucin; however, it was associated with lymphovascular invasion (χ2 = 4.12, p = 0.038) LIMITATIONS: There was limited access to clinical information gathered outside our institution. CONCLUSIONS: Our study suggests that 1) after radiation, the gross ulcer cannot be used to determine the sole area of potential residual tumor, 2) cancer cells may be found up to 3 cm distally from the gross ulcer, so the traditional 2-cm margin may not be adequate, and 3) local excision of the ulcer or no excision after apparent complete response appears to be insufficient treatment for rectal cancer.
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1757 Rectal Cancer in the Young: Is it a Different Disease?
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1757 Rectal Cancer in the Young: Is it a Different Disease?
- 1 June 2011
- Published by Elsevier in Journal of Surgical Research
- Vol. 168 (2) , 315-324
The Role of Matrix Metalloproteinases in Intestinal Epithelial Wound Healing During Normal and Inflammatory States
- 1 June 2011
- Published by Elsevier in Journal of Surgical Research
- Vol. 168 (2) , 315-324
The Role of Matrix Metalloproteinases in Intestinal Epithelial Wound Healing During Normal and Inflammatory States
- 23 February 2011
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 24 (01) , 064-070
Fecal Incontinence: Etiology, Evaluation, and Treatment
Fecal incontinence is a debilitating problem facing ∼2.2% of the U.S. general population over 65 years of age. Etiologic factors include traumatic, neurologic, congenital, and iatrogenic. Most commonly, obstetric trauma causes fecal incontinence as well as poorly performed anorectal surgery or pelvic radiation. Several severity scores and quality of life indexes have been developed to quantify incontinent symptoms. There are several nonsurgical and surgical options for the treatment of fecal incontinence. Biofeedback is among the most successful nonoperative strategies. Depending on the cause, anal sphincter repair, artificial bowel sphincter, and sacral nerve stimulation are used to treat fecal incontinence with some success. Unfortunately, fecal incontinence is an extremely difficult problem to manage: there has not been one, single treatment option that has proven to be both safe and effective in long-term studies.
- 23 February 2011
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 24 (01) , 064-070
Fecal Incontinence: Etiology, Evaluation, and Treatment
Fecal incontinence is a debilitating problem facing ∼2.2% of the U.S. general population over 65 years of age. Etiologic factors include traumatic, neurologic, congenital, and iatrogenic. Most commonly, obstetric trauma causes fecal incontinence as well as poorly performed anorectal surgery or pelvic radiation. Several severity scores and quality of life indexes have been developed to quantify incontinent symptoms. There are several nonsurgical and surgical options for the treatment of fecal incontinence. Biofeedback is among the most successful nonoperative strategies. Depending on the cause, anal sphincter repair, artificial bowel sphincter, and sacral nerve stimulation are used to treat fecal incontinence with some success. Unfortunately, fecal incontinence is an extremely difficult problem to manage: there has not been one, single treatment option that has proven to be both safe and effective in long-term studies.